[Retracted] Relationship between Hypercoagulable State and Circulating Tumor Cells in Peripheral Blood, Pathological Characteristics, and Prognosis of Lung Cancer Patients

Table 2

Comparison on clinical characteristics of patients in the hypercoagulability group and non-hypercoagulability group (n, %).

Factors	Number of cases	Hypercoagulability group (n = 76)	Non-hypercoagulability group (n = 72)	χ^2
Age (years)
≥60	85	52 (61.18)	33 (38.82)	7.716	0.005
<60	63	24 (38.10)	39 (61.90)
Gender
Male	82	40 (48.78)	42 (51.22)	0.487	0.486
Female	66	36 (54.55)	30 (45.45)
Smoking history
Yes	79	45 (56.96)	34 (43.04)	2.135	0.144
No	69	31 (44.93)	38 (55.07)
TMN stage
I, II	58	23 (39.66)	35 (60.34%)	5.223	0.022
III, IV	90	53 (58.89)	37 (41.11)
Pathology type
Squamous carcinoma	52	30 (57.69)	22 (42.31)	3.742	0.291
Adenocarcinoma	48	23 (41.92)	25 (52.08)
Small-cell carcinoma	30	17 (56.67)	13 (43.33)
Other	18	6 (33.33)	12 (66.67)
Lymph node metastasis
Yes	68	42 (61.76)	26 (38.24)	5.461	0.019
No	80	34 (42.50)	46 (57.50)